NRx Pharmaceuticals Inc.
(NRXPW)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | - | - | - | - | - | - | - |
Cost of Revenue | 5.00K | 4.00K | 2.00K | 907.41K | - | 1.01M | - |
Gross Profit | -5.00K | -4.00K | -2.00K | -907.41K | - | -1.01M | - |
Operating Income | -27.59M | -44.40M | -115.80M | -51.39M | -6.26K | -1.01M | - |
Interest Income | 494.00K | 249.00K | 18.00 | 56.00 | 1.21M | 1.09M | - |
Pretax Income | -30.16M | -39.82M | -93.06M | -51.78M | 492.63K | 82.41K | -105.03K |
Net Income | -30.15M | -35.23M | -71.72M | -12.35M | 408.43K | 66.10K | -105.03K |
Selling & General & Admin | 14.21M | 27.37M | 74.94M | 11.44M | 2.77K | 1.01M | - |
Research & Development | 13.37M | 17.03M | 20.26M | 10.63M | 3.50K | - | - |
Other Expenses | - | -505.00K | -771.00K | -10.16M | 713.19K | 1.01M | - |
Operating Expenses | 27.58M | 44.40M | 94.43M | 11.90M | 6.43K | 1.01M | - |
Interest Expense | 120.00K | - | 18.00K | 56.00K | - | - | - |
Selling & Marketing Expenses | -5.00K | - | - | - | - | - | - |
Cost & Expenses | 27.59M | 44.40M | 94.43M | 11.90M | 6.43K | 1.01M | - |
Income Tax | -9.00K | -4.58M | -21.35M | -39.43M | 84.21K | 16.31K | - |
Shares Outstanding (Basic) | 7.58M | 65.77M | 46.92M | 34.27M | 508.83K | 892.50K | 903.55K |
Shares Outstanding (Diluted) | 7.58M | 65.77M | 46.92M | 34.27M | 508.83K | 892.50K | 903.55K |
EPS (Basic) | -3.98 | -0.54 | -1.53 | -0.36 | 0.80 | 0.07 | -0.12 |
EPS (Diluted) | -3.98 | -0.54 | -1.53 | -0.36 | 0.80 | 0.07 | -0.12 |
EBITDA | -30.02M | -39.75M | -93.04M | -51.72M | -713.19K | 82.41K | -105.04K |
Depreciation & Amortization | 5.00K | 4.00K | 2.00K | 2.00K | 0.86 | 1.09M | 52.52K |